Evaluation of Ketamine as Sedative Agent in Endoscopic Retrograde Cholangiopancreatography (ERCP)
Recruiting
Phase 4
Interventional Study
Ketamine Adverse Reaction
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 16 and older
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Health Services Research
- Participants needed
- 140 (estimated)
- Sponsor
- Universiti Kebangsaan Malaysia Medical Centre · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a study evaluating the usage of Ketamine as sedative agent in ERCP. The usage of Ketamine will be compared to the standard sedation in our center, which is Midazolam in combination with Pethidine as analgesia.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Malaysian citizens of who is able to give valid consent
* Patient planned for ERCP (either emergency or elective)
Exclusion Criteria:
* Known hypersensitivity towards Ketamine or Midazolam
* Patient refusal to participate or unable to give consent
* Increased intracranial pr…
Contacts